[A new therapeutic approach to retained biliary calculi. Results in 6 patients].
A new three-phase therapeutical approach to retained biliary stones (RBS) is designed to shorten the long treatment times with Monooctanoin (Mo). In the first phase, the litholytic agent is infused to soften the stones. In the second one the calculi are crushed, and in the last complete elimination of the fragmentary stones into the duodenum is obtained after 1-2 flushings with ceruletide. In 6 patients a complete clearance of the stones was obtained (success 100%) together with a reduction in the litholytic agent dose (52%) and the infusion time (62%), in comparison with the results of using Mo. alone.
Pozzi
C
C
Caspani
P
P
Ferri
O
O
Di Padova
C
C
Tritapepe
R
R
D000328:Adult; D000368:Aged; D002210:Caprylates; D002108:Ceruletide / Q000627:therapeutic use*; D002758:Cholangiography; D002769:Cholelithiasis / Q000000981:diagnostic imaging / Q000628:therapy*; D004341:Drug Evaluation; D005260:Female; D005989:Glycerides / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012997:Solvents / Q000627:therapeutic use*
D002210:Caprylates; D005989:Glycerides; D012997:Solvents; D002108:Ceruletide; C025343:monooctanoin
Nuovo approccio terapeutico ai calcoli biliari residui. Risultati in sei pazienti.